Insights for Practitioners
Evidence-based perspectives on digital therapeutics, blended care, and the future of integrative health.
5 Trends Reshaping Digital Mental Health in 2026, and What They Mean for Your Practice
From AI-driven personalisation to new reimbursement codes, five key trends are transforming digital mental health. Here's what practitioners need to know.
ACT Goes Digital: The Evidence for Delivering Acceptance and Commitment Therapy Through Technology
The evidence for digital ACT delivery is stronger than most practitioners realise. Here's what the meta-analyses actually show, and what it means for your practice.
Why IFS Needs Digital Platforms, and Why Digital Platforms Need IFS
IFS has exploded in popularity but its evidence base hasn't kept pace. Digital platforms offer the missing infrastructure to close the gap.
The Between-Session Gap: How Digital Tools Keep Therapy Clients Engaged and on Track
Nearly half of therapy's potency is lost between sessions. Blended care models using digital tools can accelerate outcomes 2-3x and reduce dropout by 40%.
Measurement-Based Care in 2026: A Practical Guide for Wellness Practitioners
Fewer than 20% of clinicians use measurement-based care effectively. This practical guide covers instruments, interpretation, digital dashboards, and implementation.
Digital Therapeutics vs. Wellness Apps: What Practitioners Need to Know Before Choosing
The distinction between digital therapeutics and wellness apps is regulatory, clinical, and ethical. Here's a practitioner's framework for evaluation.
Your Brand, Your App: Why Clinics Are Choosing White-Label Digital Therapeutics
Generic mental health apps retain just 3-4% of users at 30 days. Branded, white-label platforms achieve 66% at 90 days. Here's why clinics are making the switch.
Therapist Burnout Is a Technology Problem: Here's How Digital Tools Solve It
Clients of burned-out therapists are 37% less likely to improve. The root cause isn't therapy itself — it's administrative burden. Technology is the solution.
The Regulatory Landscape for Digital Therapeutics in 2026: A Practitioner's Guide
From FDA clearance to Germany's DiGA scheme and France's PECAN, a comprehensive guide to navigating DTx regulation across the US, EU, and beyond.
Want to See Afterglow in Action?
Book a demo to learn how our platform can support your practice and your clients.
Book a Demo